Migdal Insurance & Financial Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-59	Closed	-$31K	–	385
2025 Q2	$31K	Buy	+59	New	+$32.9K	﹤0.01%	295
2021 Q2	–	Sell	-1,376	Closed	-$651K	–	659
2021 Q1	$651K	Buy	1,376 +860	+167%	+$419K	0.01%	293
2020 Q4	$249K	Buy	+516	New	+$279K	﹤0.01%	292
2018 Q4	–	Sell	-553	Closed	-$223K	–	794
2018 Q3	$223K	Buy	553 +328	+146%	+$125K	﹤0.01%	505
2018 Q2	$78K	Buy	225 +218	+3,114%	+$68.2K	﹤0.01%	546
2018 Q1	$2K	Buy	+7	New	+$2.44K	﹤0.01%	618
2017 Q1	–	Sell	-36	Closed	-$13K	–	490
2016 Q4	$13K	Buy	+36	New	+$13.7K	﹤0.01%	386

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Migdal Insurance & Financial Holdings's REGN Position: Q3 2025 in Review

Migdal Insurance & Financial Holdings sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 59 shares — an estimated $31K sold.

Migdal Insurance & Financial Holdings first reported a position in REGN in Q4 2016 and held it in 7 quarters. The position peaked at $651K in Q1 2021. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

Migdal Insurance & Financial Holdings reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 59 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $31K.
Migdal Insurance & Financial Holdings first reported a position in Regeneron Pharmaceuticals in Q4 2016 and held it in 7 quarters.
Migdal Insurance & Financial Holdings's Regeneron Pharmaceuticals position peaked at $651K in Q1 2021.
1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2025, filed 30 Oct 2025.